RE: OTHER PROPERTIESDLKM imo, is not focused on Morogoro or Magembe just now. Keep in mind, all these things take funding and time-dedication to develop. The focus is and should be on Mkuvia just now. If you liken it to a small pharma company- Mkuvia is near FDA approval! The other two are in the pipeline for further clinical development. Resources are and should be focused on putting the near-term value driver over the finish line. And yes- I think we get our mining licenses by or near month-end. Fingers crossed for no hiccups there.- then Ruby et al can get to pulling out the gold.